{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:14:58Z","timestamp":1778796898377,"version":"3.51.4"},"reference-count":96,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["HA6145\/3-1"],"award-info":[{"award-number":["HA6145\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.pathol.2019.10.003","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T01:20:38Z","timestamp":1574904038000},"page":"142-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell\/histiocyte rich large B-cell lymphoma"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3424-1091","authenticated-orcid":false,"given":"Sylvia","family":"Hartmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1927-3514","authenticated-orcid":false,"given":"Dennis A.","family":"Eichenauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2019.10.003_bib1","series-title":"Hodgkin's Disease and Allied Disorders","author":"Jackson","year":"1947"},{"key":"10.1016\/j.pathol.2019.10.003_bib2","first-page":"1063","article-title":"The pathology and nomenclature of Hodgkin's disease","volume":"26","author":"Lukes","year":"1966","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2019.10.003_bib3","first-page":"57","article-title":"Histological classification and occurrence of Hodgkin's disease","volume":"15","author":"Lennert","year":"1974","journal-title":"(German.) Internist (Berl)"},{"key":"10.1016\/j.pathol.2019.10.003_bib4","first-page":"1889","article-title":"European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes","volume":"96","author":"Anagnostopoulos","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib5","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1200\/JCO.2012.43.5958","article-title":"High familial risk in nodular lymphocyte-predominant Hodgkin lymphoma","volume":"31","author":"Saarinen","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.10.003_bib6","first-page":"29","article-title":"Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell-derived nodular type","volume":"138","author":"Hansmann","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2019.10.003_bib7","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","article-title":"The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)","volume":"122","author":"Hartmann","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib8","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.humpath.2015.07.006","article-title":"Immunoarchitectural patterns of progressive transformation of germinal centers with and without nodular lymphocyte-predominant Hodgkin lymphoma","volume":"46","author":"Hartmann","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.10.003_bib9","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","article-title":"Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation","volume":"27","author":"Fan","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.10.003_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ajh.23367","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma with non-invasive or early invasive growth pattern suggests an early step of the disease with a highly favorable outcome","volume":"88","author":"Carbone","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2019.10.003_bib11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1200\/JCO.2007.11.8869","article-title":"Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group","volume":"26","author":"Nogova","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.10.003_bib12","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3324\/haematol.2015.133025","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study","volume":"100","author":"Lazarovici","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.10.003_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/bjh.13540","article-title":"Childhood and adolescent nodular lymphocyte predominant Hodgkin lymphoma \u2013 a review of clinical outcome based on the histological variants","volume":"171","author":"Shankar","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.10.003_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3109\/10428194.2014.916802","article-title":"Bone marrow involvement in nodular lymphocyte predominant Hodgkin lymphoma occurs in tumors with a variant pattern","volume":"56","author":"Panjwani","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2019.10.003_bib15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/PAS.0000000000001005","article-title":"Bone marrow involvement in patients with nodular lymphocyte predominant hodgkin lymphoma","volume":"42","author":"Agbay","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.10.003_bib16","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"317","year":"2008"},{"key":"10.1016\/j.pathol.2019.10.003_bib17","first-page":"1269","article-title":"T-cell\/histiocyte-rich large B-cell lymphoma: a distinct clinicopathologic entity","volume":"20","author":"Achten","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.10.003_bib18","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/00000478-200211000-00008","article-title":"T-cell\/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells","volume":"26","author":"Lim","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.10.003_bib19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/01.pas.0000194741.87798.45","article-title":"IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma","volume":"30","author":"Prakash","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.10.003_bib20","first-page":"957","article-title":"Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease","volume":"89","author":"Marafioti","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.10.003_bib21","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1073\/pnas.94.17.9337","article-title":"Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells","volume":"94","author":"Braeuninger","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2019.10.003_bib22","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood.V93.8.2679","article-title":"Molecular analysis of single B cells from T cell-rich B-cell lymphoma shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells","volume":"93","author":"Br\u00e4uninger","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib23","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1182\/blood-2007-03-082511","article-title":"Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6","volume":"110","author":"Mottok","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib24","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1084\/jem.20080809","article-title":"Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis","volume":"205","author":"Brune","year":"2008","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.pathol.2019.10.003_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3324\/haematol.2009.010157","article-title":"Mutations in the genes coding for the NF-{kappa}B regulating factors I{kappa}B{alpha} and A20 are uncommon in nodular lymphocyte-predominant Hodgkin lymphoma","volume":"95","author":"Schumacher","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.10.003_bib26","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1182\/blood.V97.6.1845","article-title":"Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances","volume":"97","author":"Franke","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib27","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0002-9440(10)64462-8","article-title":"Comparative genomic hybridization pattern distinguishes T-cell\/histiocyte-rich B-cell lymphoma from nodular lymphocyte predominance Hodgkin's lymphoma","volume":"161","author":"Franke","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2019.10.003_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078812","article-title":"Nodular lymphocyte predominant hodgkin lymphoma and T cell\/histiocyte rich large B cell lymphoma \u2013 endpoints of a spectrum of one disease?","volume":"8","author":"Hartmann","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pathol.2019.10.003_bib29","first-page":"2609","article-title":"Macrophages in T cell\/histiocyte rich large B cell lymphoma strongly express metal-binding proteins and show a bi-activated phenotype","volume":"133","author":"Hartmann","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pathol.2019.10.003_bib30","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood-2009-12-257345","article-title":"Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome","volume":"116","author":"Steidl","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/bjh.13310","article-title":"Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell\/histiocyte rich large B cell lymphoma","volume":"169","author":"Hartmann","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.10.003_bib32","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood-2002-05-1592","article-title":"Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma","volume":"101","author":"Wlodarska","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1525-1578(10)60564-8","article-title":"Molecular cytogenetic analyses of immunoglobulin loci in nodular lymphocyte predominant Hodgkin's lymphoma reveal a recurrent IGH-BCL6 juxtaposition","volume":"7","author":"Renn\u00e9","year":"2005","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.pathol.2019.10.003_bib34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/gcc.20214","article-title":"PAX5\/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements","volume":"44","author":"Poppe","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.pathol.2019.10.003_bib35","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/leu.2015.328","article-title":"Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma","volume":"30","author":"Hartmann","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.10.003_bib36","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3324\/haematol.2018.203224","article-title":"JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell\/histiocyte-rich large B-cell lymphoma","volume":"104","author":"Schuhmacher","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.10.003_bib37","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/PAS.0b013e318165b0d6","article-title":"PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma","volume":"32","author":"Nam-Cha","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.10.003_bib38","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.humpath.2010.05.010","article-title":"Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis","volume":"41","author":"Churchill","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.10.003_bib39","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1309\/Y8KD32QGRYFN1XQX","article-title":"A\u00a0double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma","volume":"126","author":"Rahemtullah","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.10.003_bib40","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1080\/10428190802308728","article-title":"Beyond the lymphocyte predominant cell: CD4+CD8+ T-cells in nodular lymphocyte predominant Hodgkin lymphoma","volume":"49","author":"Rahemtullah","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2019.10.003_bib41","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.3390\/ijms17122127","article-title":"Characterization of the microenvironment of nodular lymphocyte predominant Hodgkin lymphoma","volume":"17","author":"Visser","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pathol.2019.10.003_bib42","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3324\/haematol.2009.009647","article-title":"T\u00a0cell\/histiocyte rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response","volume":"95","author":"Van Loo","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.10.003_bib43","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin's lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2019.10.003_bib44","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1182\/blood-2012-04-421057","article-title":"Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial","volume":"120","author":"Tan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000321567","article-title":"Refined prognostic role of CD68-positive tumor macrophages in the context of the cellular micromilieu of classical Hodgkin lymphoma","volume":"77","author":"Tzankov","year":"2010","journal-title":"Pathobiology"},{"key":"10.1016\/j.pathol.2019.10.003_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3324\/haematol.2010.031542","article-title":"Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma","volume":"96","author":"Kamper","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.10.003_bib47","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/pin.12357","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma: Clincopathological study of 25 cases from Japan with a reappraisal of tissue associated macrophages","volume":"65","author":"Eladl","year":"2015","journal-title":"Pathol Int"},{"key":"10.1016\/j.pathol.2019.10.003_bib48","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.4049\/jimmunol.0902223","article-title":"Matrix architecture dictates three-dimensional migration modes of human macrophages: differential involvement of proteases and podosome-like structures","volume":"184","author":"Van Goethem","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pathol.2019.10.003_bib49","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2011.050138","article-title":"Peripheral blood lymphocyte\/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma","volume":"97","author":"Porrata","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.10.003_bib50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2141.2012.09067.x","article-title":"Peripheral blood lymphocyte\/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma","volume":"157","author":"Porrata","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.10.003_bib51","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00428-018-2460-8","article-title":"A\u00a0high number of IgG4-positive plasma cells rules out nodular lymphocyte predominant Hodgkin lymphoma","volume":"473","author":"Kiil","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2019.10.003_bib52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1182\/blood-2011-03-341560","article-title":"Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma","volume":"118","author":"Saarinen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib53","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ajh.23482","article-title":"Looking for familial nodular lymphocyte-predominant Hodgkin lymphoma","volume":"88","author":"Merli","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2019.10.003_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080131","article-title":"Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects","volume":"8","author":"Lorenzi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pathol.2019.10.003_bib55","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1182\/blood.V99.4.1492","article-title":"Germline FAS gene mutation in a case of ALPS and NLP Hodgkin lymphoma","volume":"99","author":"van den Berg","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib56","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/1097-0142(19850215)55:4<683::AID-CNCR2820550402>3.0.CO;2-O","article-title":"Morphologic, immunologic, enzymehistochemical and chromosomal analysis of a cell line derived from Hodgkin's disease. Evidence for a B-cell origin of Sternberg-Reed cells","volume":"55","author":"Poppema","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2019.10.003_bib57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-3-642-83781-4_7","article-title":"The typical Reed-Sternberg phenotype and Ig gene rearrangement of Hodgkin's disease derived cell line ZO indicating a B cell origin","volume":"117","author":"Poppema","year":"1989","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.pathol.2019.10.003_bib58","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.humpath.2006.01.018","article-title":"BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma-derived cell line DEV","volume":"37","author":"Atayar","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.10.003_bib59","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/leu.2014.201","article-title":"The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing","volume":"28","author":"Liu","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.10.003_bib60","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.celrep.2015.10.008","article-title":"Genomic alterations in CIITA are frequent in primary mediastinal large B cell lymphoma and are associated with diminished MHC class II expression","volume":"13","author":"Mottok","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.pathol.2019.10.003_bib61","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood-2007-09-112128","article-title":"Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes","volume":"111","author":"Ma","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.humpath.2017.10.029","article-title":"Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes","volume":"71","author":"Panjwani","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.10.003_bib63","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2019.10.003_bib64","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood-2017-03-770719","article-title":"Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma","volume":"130","author":"Carey","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib65","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1200\/JCO.2014.60.4363","article-title":"Long-term course of patients with stage IA nodular lymphocyte-predominant hodgkin lymphoma: a report from the German Hodgkin Study Group","volume":"33","author":"Eichenauer","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.10.003_bib66","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1200\/JCO.2009.24.0945","article-title":"Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up","volume":"28","author":"Chen","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.10.003_bib67","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1182\/blood-2011-06-361055","article-title":"Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group","volume":"118","author":"Eichenauer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib68","first-page":"29","article-title":"Hodgkin lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","author":"Eichenauer","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pathol.2019.10.003_bib69","first-page":"535","article-title":"Hodgkin lymphoma in adults","volume":"115","author":"Brockelmann","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.pathol.2019.10.003_bib70","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1200\/JCO.2015.65.3469","article-title":"Minimal treatment of low-risk, pediatric lymphocyte-predominant Hodgkin lymphoma: a report from the Children's Oncology Group","volume":"34","author":"Appel","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.10.003_bib71","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/cncr.22762","article-title":"Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma","volume":"110","author":"Mauz-Korholz","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2019.10.003_bib72","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood-2018-10-877761","article-title":"Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma","volume":"133","author":"Borchmann","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib73","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1182\/blood-2011-07-365932","article-title":"Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome","volume":"118","author":"Savage","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib74","first-page":"275","article-title":"Long-term outcome of patients with nodular lymphocyte-predominant Hodgkin lymphoma treated within the randomized HD7-HD15 trials: an analysis from the German Hodgkin Study Group","volume":"102","author":"Eichenauer","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.10.003_bib75","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1182\/blood-2013-12-541078","article-title":"Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis","volume":"123","author":"Xing","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib76","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1182\/blood-2017-02-766121","article-title":"Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma","volume":"130","author":"Fanale","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib77","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/ajh.25607","article-title":"The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma","volume":"94","author":"Hartmann","year":"2019","journal-title":"Am J Hematol"},{"issue":"Suppl 1","key":"10.1016\/j.pathol.2019.10.003_bib78","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/13.S1.44","article-title":"Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell\/histiocyte-rich B cell lymphoma","volume":"13","author":"Rudiger","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pathol.2019.10.003_bib79","first-page":"599","article-title":"Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent \u201clarge cell lymphoma\u201d. Histological progression or composite malignancy?","volume":"12","author":"Sundeen","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.10.003_bib80","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0046-8177(89)80007-3","article-title":"Nodular paragranuloma can transform into high-grade malignant lymphoma of B type","volume":"20","author":"Hansmann","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.10.003_bib81","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1080\/1042819031000149421","article-title":"Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group","volume":"45","author":"Huang","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2019.10.003_bib82","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1200\/JCO.2009.24.9516","article-title":"Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma","volume":"28","author":"Al-Mansour","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.10.003_bib83","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.24819","article-title":"Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group","volume":"116","author":"Biasoli","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2019.10.003_bib84","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1365-2559.2011.04054.x","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma and diffuse large B-cell lymphoma: a study of six cases concurrently involving the same site","volume":"59","author":"Cotta","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.10.003_bib85","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/1471-2407-14-332","article-title":"Diffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathology","volume":"14","author":"Hartmann","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pathol.2019.10.003_bib86","doi-asserted-by":"crossref","first-page":"72197","DOI":"10.18632\/oncotarget.12363","article-title":"A\u00a0strong host response and lack of MYC expression are characteristic for diffuse large B cell lymphoma transformed from nodular lymphocyte predominant Hodgkin lymphoma","volume":"7","author":"Schuhmacher","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2019.10.003_bib87","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajh.24927","article-title":"High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: a retrospective study by the European Society for Blood and Marrow Transplantation \u2013 Lymphoma Working Party","volume":"93","author":"Akhtar","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2019.10.003_bib88","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood-2018-02-836437","article-title":"Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group","volume":"132","author":"Eichenauer","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib89","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1182\/blood-2007-03-078725","article-title":"Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)","volume":"111","author":"Schulz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib90","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/leu.2015.321","article-title":"Ofatumumab in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: results of a phase II study from the German Hodgkin study group","volume":"30","author":"Eichenauer","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.10.003_bib91","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.ijrobp.2008.09.049","article-title":"Low-dose involved-field radiotherapy as alternative treatment of nodular lymphocyte predominance Hodgkin's lymphoma","volume":"74","author":"Haas","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.pathol.2019.10.003_bib92","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bbmt.2013.03.008","article-title":"High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphoma","volume":"19","author":"Karuturi","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.pathol.2019.10.003_bib93","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/bjh.13979","article-title":"Relapsed or poorly responsive nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents \u2013 a report from the United Kingdom's Children's Cancer and Leukaemia Study Group","volume":"173","author":"Shankar","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.10.003_bib94","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1002\/ajh.23989","article-title":"Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant Hodgkin lymphoma: long-term outcomes from a 30-year experience","volume":"90","author":"Eyre","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2019.10.003_bib95","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1182\/blood-2015-08-665505","article-title":"Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution","volume":"127","author":"Kenderian","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.10.003_bib96","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.humpath.2013.02.010","article-title":"Intranodular clusters of activated cells with T follicular helper phenotype in nodular lymphocyte predominant Hodgkin lymphoma: a pilot study of 32 cases from Finland","volume":"44","author":"Nathwani","year":"2013","journal-title":"Hum Pathol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519304222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519304222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T13:45:04Z","timestamp":1577454304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302519304222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0031302519304222"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2019.10.003","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell\/histiocyte rich large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2019.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}